Sign in
4

Changes in Ownership

XTL BIOPHARMACEUTICALS LTD Filed Acc 0001144204-08-061015

Options or other derivatives

  • Director acquired 300,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

WEINER BEN-ZION · Director

Table II: Derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2008-10-10 Grant or award : show line 1 in the form Options to Purchase Ordinary Shares +300,000 $0.20 $59,400 2,300,000 D
Loading xslF345X03/v130474_ex.xml…